Recombinant Plasmepsin 1 from the Human Malaria Parasite Plasmodium falciparum : Enzymatic Characterization, Active Site Inhibitor Design, and Structural Analysis
about
Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparumPlasmepsin Inhibitory Activity and Structure-Guided Optimization of a Potent Hydroxyethylamine-Based Antimalarial HitThe Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking InvestigationsDisulfide linkages in Plasmodium falciparum plasmepsin-i are essential elements for its processing activity and multi-milligram recombinant production yieldEnzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium bergheiCatestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparumComputational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.Characterization of gut-associated cathepsin D hemoglobinase from tick Ixodes ricinus (IrCD1).Structural studies of vacuolar plasmepsinsProteases in malaria parasites - a phylogenomic perspective.Comparative Genomics and Systems Biology of Malaria Parasites Plasmodium.From crystal to compound: structure-based antimalarial drug discovery.
P2860
Q27667575-D01D06D3-0CE8-48C6-B7BB-49C2C2E86E5BQ27684238-994F07A7-A065-4977-891C-A21F43428AD9Q28066944-6724E80A-FC58-4434-9FCF-9695EDC673BCQ28540029-9A4A5A34-BC39-4131-8D21-3248A7BC1510Q28550537-95D12879-14C4-4DA5-AD5C-F34A064C44EEQ33685005-6332754A-1004-4965-83CA-FF68498D266FQ33961367-C18C0494-961F-4E71-AEA9-3DB2EAE56A8AQ34249141-7344A857-724B-4470-AB60-1674D6A6249FQ35159276-4AF04AB5-4722-4E43-B8E3-CB315CE0F3D9Q35228790-5E7F04B3-5EFE-426C-AE3F-D5E5BC9D51EAQ37351351-A9371BBE-D7DD-4092-99B5-BF978E21E7EBQ38227796-E147324B-1F86-4BD5-A74C-6EDC1B3E4011
P2860
Recombinant Plasmepsin 1 from the Human Malaria Parasite Plasmodium falciparum : Enzymatic Characterization, Active Site Inhibitor Design, and Structural Analysis
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@ast
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@en
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@nl
type
label
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@ast
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@en
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@nl
prefLabel
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@ast
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@en
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@nl
P2093
P2860
P356
P1433
P1476
Recombinant Plasmepsin 1 from ...... esign, and Structural Analysis
@en
P2093
Arthur H Robbins
Ben M Dunn
Charles A Yowell
David Rodríguez
Hugo Gutiérrez-de-Terán
John B Dame
Melissa R Marzahn
Scott H McClung
Stanley M Stevens
P2860
P304
P356
10.1021/BI802059R
P407
P577
2009-05-19T00:00:00Z